NCT06096623Completed
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment
The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparities in Cancer Treatment Delay
Source: ClinicalTrials.gov · Last updated 26 Jun 2026
Brief summary (registry, in English)
This study assesses the feasibility and acceptability of a brief electronic patient-reported outcome (ePRO) tool that allows patients to self-identify impending delays. The risk of treatment delays according to tumor type and race will be measured by both ePRO and electronic health record (EHR) tools. Data from this study and the association of social determinants of health could be useful to flag patients at risk of delay and due timely intervention for modifiable treatment barriers. The prediction of the risk of treatment delay will be helpful to design another study using electronic tracking systems to prevent cancer treatment delays. The long-term goal of this research is to alert care teams when patients may be at risk of treatment days and to help patients get treatment faster. It was planned to enroll a total of 240 subjects with newly diagnosed cancer. Sixty colorectal and 180 breast cancer patients will be included.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 17 Oct 2023
- Start date
- 6 Nov 2023
- Primary completion date
- 5 Jun 2025
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Diseases
- Colorectal cancer
- NCT number
- NCT06096623
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 6 Nov 2023 to the primary completion date, 5 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient unwilling or unable to receive electronic survey links via email or text link on a mobile device, tablet, laptop, or desktop computer.
- Patient unwilling or unable to provide verbal or signed consent to participate.
- Patient cannot read and speak English.
- Patients who do not have email access or a smartphone are able to receive Short Message/Messaging Service (SMS) text messages.
Who the study is looking for
- In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
- Male and female patients of age \>18 years.
- Pathologic diagnosis of breasts or colorectal cancer within 6 weeks (42 days) prior to the enrollment date.
- Have not yet initiated cancer treatment on the date of enrollment.
- Indicate intent to receive cancer treatment at the University of North Carolina.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of North Carolina Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.